See All
Preferences
My Communities
My Discussions
My Email Digests

FOR IMMEDIATE RELEASE
Raleigh, NC, USA July 27, 2010
Helia Medical and Siogen Biotech announced today that they have finalized an agreement for the development of a new oral insulin delivery system for type 1 diabetes. The arrangement, which is effective as of July 20, 2010, provides for the development of a SiosomeĀ® nanoparticle containing synthetic human insulin designed to be administered orally and then time-released into the bloodstream over a 12-hour period. Financial terms and specific details have not been disclosed.
Under the agreement, Helia Medical and Siogen Biotech shall work together to develop this drug for canine type 1 diabetes. The project shall commence in the third quarter of 2010. The partnership on this project will lead the veterinary and medical world to a new personalized method to manage diabetes in a more controlled and patient-friendly manner.
Siogen Biotech is Malaysia based company that focuses on developing nanoparticle delivery systems for many different drugs, compounds and substances. Siogen is a world leader in the production of silane-based nanoparticles. Siogen's main office is located in Kuala Lumpur, Malaysia and has other facilities in Germany and the UK. www.siogen.com
Helia Medical is a Wisconsin based company with operations in Raleigh, North Carolina. Helia Medical's mission is developing novel and effective drugs, devices and nanoparticles for the veterinary medical world. Helia Medical uses many cutting-edge human medical developments and applies them to veterinary medical applications. www.heliamedical.com
Helia Medical and Siogen Biotech look forward to working together on this project as well as others in the future. Many of the developments from this partnership should directly advance not only veterinary medicine, but also human medicine worldwide.
SOURCE Helia Medical www.heliamedical.com Copyright (C) 2010View Thread
Take the Poll
Poll Results
-
Yes40% (2)
-
No40% (2)
-
Not sure20% (1)

I came up with the oral siosome insulin idea on May 4, 2010. We are trying to move fast on this, and get in veterinary in 3 years. I believe it might take 7 years to get into human medicine. I get frustrated too when I see a child or person who has a disability that I know we could help. I feel down that I can't create something new quickly and help them. I guess the solution is to make drug approval time and procedure faster by making it a key point of elections to the House and Senate. The FDA could move faster if new laws were put into place to expedite things, however we are sue happy society and hence the process we now have.
As a company Helia can't afford the approx. $80M to take this to market. I personally try to do the best I can and use the gifts God gave me. I think that is all I can do. I believe this application, if successful, will be for sale sooner in other countries before the US. Please understand that there are some of us out in the world trying to help and we don't worry about money so much as we do who we can help.
LeighView Thread
Take the Poll
Poll Results
-
Yes40% (2)
-
No40% (2)
-
Not sure20% (1)

Helia Medical and Siogen Biotech announced today that they have finalized an agreement for the development of a new oral insulin delivery system for type 1 diabetes. The arrangement, which is effective as of July 20, 2010, provides for the development of a SiosomeĀ® nanoparticle containing synthetic human insulin designed to be administered orally and then time-released into the bloodstream over a 12-hour period. Financial terms and specific details have not been disclosed.
Under the agreement, Helia Medical and Siogen Biotech shall work together to develop this drug for canine type 1 diabetes. The project shall commence in the third quarter of 2010. The partnership on this project will lead the veterinary and medical world to a new personalized method to manage diabetes in a more controlled and patient-friendly manner.
Siogen Biotech is Malaysia based company that focuses on developing nanoparticle delivery systems for many different drugs, compounds and substances. Siogen is a world leader in the production of silane-based nanoparticles. Siogen's main office is located in Kuala Lumpur, Malaysia and has other facilities in Germany and the UK. www.siogen.com
Helia Medical is a Wisconsin based company with operations in Raleigh, North Carolina. Helia Medical's mission is developing novel and effective drugs, devices and nanoparticles for the veterinary medical world. Helia Medical uses many cutting-edge human medical developments and applies them to veterinary medical applications. www.heliamedical.com
Helia Medical and Siogen Biotech look forward to working together on this project as well as others in the future. Many of the developments from this partnership should directly advance not only veterinary medicine, but also human medicine worldwide.
SOURCE Helia Medical www.heliamedical.com Copyright (C) 2010View Thread
See Related Eating & Diet Communities
Women's Health Newsletter
Find out what women really need.
Other Diabetes Information
- Diabetes Health Center
- Dieting Club: 50 – 100 Lbs Member Community Get Support from Members Like You!
- Blog : Conquering Diabetes with Michael Dansinger, MD
-
More Related Communities
The opinions expressed in WebMD User-generated content areas like communities, reviews, ratings, or blogs are solely those of the User, who may or may not have medical or scientific training. These opinions do not represent the opinions of WebMD. User-generated content areas are not reviewed by a WebMD physician or any member of the WebMD editorial staff for accuracy, balance, objectivity, or any other reason except for compliance with our Terms and Conditions. Some of these opinions may contain information about treatments or uses of drug products that have not been approved by the U.S. Food and Drug Administration. WebMD does not endorse any specific product, service, or treatment.
Do not consider WebMD User-generated content as medical advice. Never delay or disregard seeking professional medical advice from your doctor or other qualified healthcare provider because of something you have read on WebMD. You should always speak with your doctor before you start, stop, or change any prescribed part of your care plan or treatment. WebMD understands that reading individual, real-life experiences can be a helpful resource, but it is never a substitute for professional medical advice, diagnosis, or treatment from a qualified health care provider. If you think you may have a medical emergency, call your doctor or dial 911 immediately.
Health Solutions From Our Sponsors
©2005-2013 WebMD, LLC. All rights reserved.
WebMD does not provide medical advice, diagnosis or treatment. See additional information.

